<DOC>
	<DOCNO>NCT02327923</DOCNO>
	<brief_summary>Comparison intraoperative infusion lidocaine esmolol postoperative requirement opioid postoperative pain management laparoscopic cholecystectomy decrease opioid related side effect enhance postoperative recovery multimodal analgesia approach .</brief_summary>
	<brief_title>Intraoperative Lidocaine Infusion vs. Esmolol Infusion Postoperative Analgesia Laparoscopic Cholecystectomy</brief_title>
	<detailed_description>Postoperative pain abdominal surgery include many form distress , spontaneous pain rest ; pain movement , include respiration ; visceral pain arise damage internal organ surgery . Acute pain laparoscopic cholecystectomy complex nature . The pain pattern resemble pain laparoscopic procedure , suggest analgesic treatment might procedure specific multimodal . Three component describe : incisional pain dominant , visceral deep pain , shoulder refer pain . Opioids commonly use postoperative analgesia laparoscopic cholecystectomy . However , associate many side effect delay discharge . In addition , opioids offer quality postoperative pain relief one would expect , probably pain specific laparoscopic cholecystectomy . A single agent unlikely treat three type pain . Therefore multimodal approach require . Low-dose IV lidocaine easy administer , well-established analgesic , anti-hyperalgesic , anti-inflammatory effect , minimal toxicity commonly study dos ( typically 1.5-3 mg/kg/h ) . Because postoperative pain large extent inflammatory phenomenon , administration systemic local anesthetic , inflammatory modulatory property , could significantly reduce pain therefore allow rapid discharge . Lidocaine excellent safety record administer low-dose infusion . In addition , intravenous lidocaine effective modality treat visceral pain . Esmolol propose alternative intraoperative use opioids , find facilitate fast-tracking process speed home-readiness patient undergoing outpatient surgery . The various mechanism opioids dose spar concomitant use β-adrenergic antagonist propose time time suppression stress hormone pro-inflammatory cytokine , alteration hepatic drug metabolism , activation G-coupled protein cell membrane , central analgesia nothing conclusive establish yet . After pre operative evaluation , patient premedicated oral diazepam ( 0.1-0.2 mg/kg ) night 2 hour surgery . Informed consent obtain patient . Patients instruct pre-anaesthetic visit use visual analogue scale ( 0-100 mm ) 0 pain 100 bad imaginable excruciate pain . They also inform ask pain ( VAS score ) character first 24 hr surgery . Pain characterize incisional ( incisional , sharp , localize ) , visceral ( poorly localize , deep , vague ) shoulder tip pain . Both patient investigator observe outcome blind assignment patient group study . The investigator enter operate room responsible data collection post operative period data analysis . On arrival patient preoperative hold area , randomly assign two group use computer generate random number . Details group assignment case number keep set seal opaque envelope . The anesthesia staff open envelope prepare drug accordingly . The attend anesthesiologist involve data collection analysis , follow standard general anaesthesia protocol study . On arrival operating room , standard monitoring establish baseline heart rate , non-invasive B.P , oxygen saturation bispectral index ( BIS ) value ( Covidien ) record . A peripheral vein cannulate administration IV fluid 18 G cannula patient receive IV pre-hydration 10 ml/kg ringer 's lactate solution 15 min.. Patient preoxygenated use 100 % oxygen 3 minute . General anesthesia induce IV fentanyl 1.5 µg/kg , propofol 2-2.5 mg/kg till cessation verbal response tracheal intubation facilitate vecuronium 0.1mg/kg IV . The lung mechanically ventilate 50 % mixture air oxygen maintain ETCO2 35 45 mm Hg . At induction , lidocaine group ( L group ) patient receive 1.5 mg/kg lidocaine IV bolus . The lidocaine infusion ( B-Braun ) 1.5 mg/kg/h start immediately induction anesthesia . The esmolol group ( E group ) receive IV bolus 0.5 mg/kg induction follow continuous infusion ( B-Braun ) esmolol ( 5-15 μg/kg/min ) titrate maintain heart rate within 25 % baseline value . Inj . paracetamol 1 gm IV infusion start induction give 15 min . Anesthesia maintain group isoflurane adjust upto 2.5 % maintain MAP within 20 % baseline BIS value 50 60 . An orogastric tube insert every patient surgical incision . No supplemental opioids use surgery . Supplemental neuromuscular blockade achieve vecuronium IV bolus dos observe curare notch capnometry . Inj . ketorolac 30 mg IV ondansetron 4mg ( 0.1mg/kg ) IV give removal gall bladder . Any episode intraoperative hypotension ( MAP low 65 mm Hg ) bradycardia ( heart rate &lt; 50 bpm ) treat ephedrine 5 mg atropine 0.4 mg IV respectively . Patient position monitor Hasson surgical technique use . Each port site infiltrate 3ml 2 % lidocaine incision . Pneumoperitoneum achieve carbon dioxide . Patients position 30 degree reverse trendelenburg position tilt toward left slowly . Non-invasive blood pressure assessment , oximetry , ECG end tidal CO2 continually monitor anesthesia . During pneumoperitoneum , control ventilation adjust maintain ETC02 35 45 mm Hg . Intra-abdominal pressure keep 15 mm Hg laparoscopy . At end surgery , patient return supine position carbon dioxide leave peritoneal cavity expel slow abdominal decompression . Isoflurane discontinue last skin suture , lignocaine esmolol infusion also stop completion surgery . 10 ml 0.25 % Bupivacaine infiltrate incision site . Residual neuromuscular block reverse neostigmine 0.05 mg/kg IV glycopyrrolate 0.01 mg/kg IV . Thorough gastric oropharyngeal suction do . Then , orogastric tube remove endotracheal extubation . Trachea extubated operate table . Then , patient transfer postanesthesia care unit . Postoperative Care observation In PACU , non-invasive blood pressure , heart rate , respiration , temperature monitor nurse unaware study . Pain awaken note use VAS scale . Pain include character assess rest movement VAS every 30 min investigator nurse SOS basis patient 's request . If VAS pain 3 rest , morphine 2 mg IV ( 0.01- 0.02 mg/kg ) Tramadol 50 mg IV administer PACU ward respectively repeat SOS basis . It stop adverse effect notice include increased sleepiness , respiratory depression ( SPO2 &lt; 90 % , R.R &lt; 8 per minute ) . Ondansetron 4 mg IV administer persistent nausea ( last &gt; 5 min ) vomiting , require basis . In investigator institution , step-down high dependency unit available patient transfer ward directly PACU follow outcome parameter observe 3 , 6 , 8 , 12 24 h surgery .</detailed_description>
	<mesh_term>Gallstones</mesh_term>
	<mesh_term>Cholelithiasis</mesh_term>
	<mesh_term>Cholecystolithiasis</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Atropine</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Glycopyrrolate</mesh_term>
	<mesh_term>Esmolol</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Neostigmine</mesh_term>
	<mesh_term>Vecuronium Bromide</mesh_term>
	<criteria>Adult female patient ASA physical status I II , age 18 60 year undergoing elective laparoscopic cholecystectomy general anaesthesia . Refusal give consent . ASA physical status III . Inability comprehend pain assessment score severe mental impairment . Difficult intubation . Pregnancy . Morbid obesity . History epilepsy . History allergy drug use study . History ongoing use opioids beta adrenergic receptor antagonist . Baseline heart rate le 50 beat per minute . Placement intraabdominal drain ; subhepatic subdiaphragmatic drain . Presence pain immediately surgery . Chronic pain gall stone disease . Gastrointestinal ulceration , bleed disorder . Peritonitis ( include previous ) , perforate gall bladder , severe acute cholecystitis , know choledocholithiasis , previous upper abdominal surgery . Conversion laparotomy laparoscopy .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Laparoscopic cholecystectomy</keyword>
	<keyword>lidocaine infusion</keyword>
	<keyword>Esmolol infusion</keyword>
	<keyword>Postoperative opioid consumption</keyword>
	<keyword>Multimodal analgesia</keyword>
</DOC>